The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
Biomed Res Int
; 2021: 6670798, 2021.
Article
en En
| MEDLINE
| ID: mdl-33681368
ABSTRACT
Recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), has led to a worldwide pandemic with millions of infected patients. Alteration in humans' microbiota was also reported in COVID-19 patients. The alteration in human microbiota may contribute to bacterial or viral infections and affect the immune system. Moreover, human's microbiota can be altered due to SARS-CoV-2 infection, and these microbiota changes can indicate the progression of COVID-19. While current studies focus on the gut microbiota, it seems necessary to pay attention to the lung microbiota in COVID-19. This study is aimed at reviewing respiratory microbiota dysbiosis among COVID-19 patients to encourage further studies on the field for assessment of SARS-CoV-2 and respiratory microbiota interaction.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Disbiosis
/
Micobioma
/
SARS-CoV-2
/
COVID-19
/
Pulmón
Idioma:
En
Revista:
Biomed Res Int
Año:
2021
Tipo del documento:
Article